TITLE

Double-Blind, Crossover Study of the Clinical Efficacy and the Hemorheological Effects of Pentoxifylline in Patients With Occlusive Arterial Disease of the Lower Limbs

AUTHOR(S)
Strano, A.; Davi, G.; Avellone, G.; Novo, S.; Pinto, A.
PUB. DATE
July 1984
SOURCE
Angiology;Jul1984, Vol. 35 Issue 7, p459
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The effect of a 3 month daily administration of 800 mg pentoxifylline (Trental 400 bds) or placebo was assessed under double blind crossover design in 18 patients (12 males and 6 females) with peripheral occlusive arterial disease in respect of painfree walking distance and various hemorheological and hemostasiological variables, platelet aggregation, serum cholesterol and triglycerides. In first treatment period walking distance significantly increased with pentoxifylline by 46% from baseline 121±15 m and by 4% with placebo from baseline 134±18 m. Pentoxifylline administration furthermore yielded significant de- crease in whole blood and plasma viscosity and significant increase in erythrocyte deformability. This was paralleled by distinct reduction of fibrinogen, platelet aggregation and euglobuline lysis time, also plethysmographic variables showed positive changes pointing to improvement of limb perfusion. The results of the study suggest that treatment of peripheral occlusive vascular disease by a drug improving blood fluidity through correction of hemorheological and he- mostasiological factors turns especially promising and beneficial since the action centers finally on the languishing microcirculation in the ischemic tissue.
ACCESSION #
16352730

 

Related Articles

  • A randomized trial of iloprost in patients with intermittent claudication. Creager, Mark A.; Pande, Reena L.; Hiatt, William R. // Vascular Medicine;2008, Vol. 13 Issue 1, p5 

    Prostanoids, which promote vasodilation and reduce platelet aggregation, have been proposed as candidate therapies for intermittent claudication due to peripheral arterial disease (PAD). However, studies of these medications have yielded inconsistent results. This study tested the hypothesis...

  • Identification of Potential Predisposition to Clinical Atherosclerosis: A Clinical Concept Based on Integration of Significant Blood Parameters with Platelet Aggregation Scores. Kaplan, Alexander; Kaplan, Svetlana; Marcoe, Karen F.; Sauvage, Lesler R.; Hammond, William P. // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p174 

    We sought to develop a predictive method, based on the integration of blood parameters found to be significantly associated with thrombosis and progression of atherosclerosis, that would be more accurate than primary reliance on elevation of separate risk factors. The study involved 1,034 male...

  • Comparison of the Effects of Policosanol and Atorvastatin on Lipid Profile and Platelet Aggregation in Patients with Dyslipidaemia and Type 2 Diabetes Mellitus. Castaño, Gladys; Fernández, Lilia; Mas, Rosa; Illnait, José; Mesa, Meylin; Fernández, J.C. // Clinical Drug Investigation;2003, Vol. 23 Issue 10, p639 

    Background: Diabetes mellitus and hypercholesterolaemia increase the risk for coronary heart disease, with type 2 diabetes mellitus being the most prevalent form of diabetes, frequently accompanied by dyslipidaemia. The main goal of dyslipidaemia control in nondiabetic and diabetic patients is...

  • Citric Acid Enhances the Antithrombotic Effect of Aspirin in Many Aspirin-Resistant Subjects. Kaplan, Svetlana; Kaplan, Alexander; Marcoe, Karen F.; Hammond, William P.; Fisher, Lloyd D.; Sauvage, Lester R. // Clinical & Applied Thrombosis/Hemostasis;Jan1997, Vol. 3 Issue 1, p54 

    This study had three objectives: (1) to determine the frequency of high platelet aggregators in a consecutive series of 268 apparently healthy volunteers who presented to our Center; (2) to assess the inhibitory effect of aspirin (ASA) on these high aggregators; (3) to determine, in a...

  • Red Cell Flexibility and Platelet Aggregation in Patients with Chronic Obstructive Vascular Disease (COAD) and Study of Therapeutic Approaches. Ambrus, J. L.; Ambrus, C. M.; Taheri, S. A.; Gastpar, H.; Reddington, M. M.; Taheri, P.; Kahn, E. A.; Schattman, G. L.; Dean, L. S.; Moore, R. H. // Angiology;Jul1984, Vol. 35 Issue 7, p418 

    The red blood cell flexibility was studied in the blood of twenty patients with severe peripheral vascular disease and twenty matched controls. Patients exhibited significantly less red cell flexibility than controls. In both groups there was an inverse relationship between age and red cell...

  • Platelet Aggregation in Patients With Moyamoya Disease. Maki, Yutaka; Nose, Tadao; Tanoue, Kenjiro; Abe, Tsukasa // Angiology;Aug1981, Vol. 32 Issue 8, p522 

    Platelet aggregation was studied by giving ADP or adrenalin to 28 patients with Moyamoya disease. There were 7 males and 21 females, and 27 normal controls, 11 males and 16 females. We found that 2 μM of ADP, and 9.1 and 22.7 μM of adrenalin induced statistically significant increases in...

  • Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents. Goto, S. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Jun2004, Vol. 2 Issue 2, p149 

    For many years, platelet aggregation, which is mediated exclusively by the binding of fibrinogen to activated glycoprotein (GP) IIb / IIIa, has been used for the screening of antiplatelet agents. However, clinical experience with anti-GP IIb / IIIa agents, which can completely inhibit platelet...

  • Combination Antiplatelet Therapy in Patients with Peripheral Vascular Bypass Grafts. Smout, Jonathan D.; Mikhailidis, Dimitri P.; Shenton, Brian K.; Stansby, Gerard // Clinical & Applied Thrombosis/Hemostasis;Jan2004, Vol. 10 Issue 1, p9 

    Peripheral bypass graft occlusion occurs in approximately 25% of cases in the 5 years following surgery; hence, therapies directed at reducing the tendency toward thrombotic occlusion are of clinical importance. This trial was conducted to determine if the addition of clopidogrel to aspirin...

  • HYPERURICEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Seitanidis, Basil; Balas, P.; Karabelis, A.; Tripolitis, A. // Angiology;Apr1974, Vol. 25 Issue 4, p257 

    Serum uric acid was found elevated in 25 out of 45 patients with Peripheral arterial occlusive disease. At the present time neither the precise pathogenesis of PAOD nor the exact role of SUA in vascular disorders has been determined. There exists some data suggesting on the one hand a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics